TGFB1 and breast cancer: GRHL2 was found to be downregulated specifically in claudin-low subclass breast cancers and to suppress TGF-β-induced, Twist-induced or spontaneous EMT partially by suppressing ZEB1 expression by directly binding to the ZEB1 promoter [52].